Abstract
A substantial number of patients with Graves’ disease have significant and sometimes disabling abnormalities in sites anatomically remote from the thyroid, such as in orbital tissues (ophthalmopathy), pretibial skin (dermopathy), and bones of the extremities (acropachy).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adams DD, Purves HD, Abnormal responses in the assay of thyrotropin, Proc Univ Otago Med School 34:11–12, 1956.
McKenzie JM, Delayed response to serum from thyrotoxic patients, Endocrinology 62:865–868, 1958.
Kriss JP, Pleshakov V, Chien JR, Isolation and identification of the long-acting thyroid stimulator and its relation to hyperthyroidism and circumscribed pretibial myxedema, J Clin Endocrinol Metab 24:1005–1028, 1964.
McKenzie JM, Zakarija M, LATS in Graves’ disease, Recent Prog Horm Res 33:29–53, 1977.
Yavin E, Yavin Z, Schneider MD, Kohn LD, Monoclonal antibodies to the thyrotropin receptor: implications for receptor structure and the action of autoantibodies in Graves’ disease, Proc Natl Acad Sci USA 78:3180–2184, 1980.
Matsukura N, Yamada Y, Nohara Y, Konishi J, Kasagi K, Kojima H, Wataya K, Familial neonatal transient hypothyroidism due to maternal TSH-binding inhibitor immunoglobulins, New Engl J Med 303:738–741, 1980.
Valente WA, Vitti P, Yavin Z, Yavin E, Rotella CM, Grollman EF, Toccafondi RS, Kohn LD, Monoclonal antibodies to the thyrotropin receptor: Stimulating and blocking antibodies derived from the lymphocytes of patients with Graves’ disease, Proc Natl Acad Sci USA 79:6680–6684, 1982.
Atkinson S, Kendall-Taylor P, The stimulation of thyroid hormone secretion in vitro by thyroid-stimulating antibodies, J Clin Endocrinol Metab 53:1263–1266, 1981.
Kodama K, Sikorska P, Bandy-Dafoe K, Wall JR, Demonstration of a circulating autoantibody against soluble eye-muscle antigen in Graves’ ophthalmopathy, Lancet ii:1353–1356 1982.
Faryna M, Nauman J, Gardos A, Measurement of autoantibodies against human eye muscle membranes in Graves’ ophthalmopathy, Brit Med J 290:191–192, 1985.
Atkinson S, Holcombe M, Kendall-Taylor P, Ophthalmopathic immunoglobulin in patients with Graves’ ophthalmopathy, Lancet 11:374–376, 1984.
Kendall-Taylor P, Atkinson S, Holcombe M, A specific IgG in Graves’ ophthalmopathy and its relation to retro-orbital and thyroid autoimmunity, Brit Med J 288:1183–1186, 1984.
Salvi M, How JS, Wall JR, Detection of autoantibodies against affinity purified orbital membrane antigens in Graves’ ophthalmopathy using a competitive binding ELISA, 61st Meeting, Am Thy Assoc, Abst T-8, 1986.
Baker JR, Weetman AP, Wartofsky L, Nutman T, Burman KD, Serum immunoglobulins in patients with Graves’ ophthalmopathy directed against unique determinants of porcine eye muscle, Clin Res 34:420A, 1986.
Wang, PW, Hiromatsu Y, Laryea E, Sosu L, How J, Wall JR, Immunologically mediated cytotoxicity against human eye muscle cells in Graves’ ophthalmopathy, J Clin Endocrinol Metab 63:316–322, 1986.
Sikorska H, Wall JR, Failure to detect eye muscle membrane specific antibodies in Graves’ ophthalmopathy, Brit Med J 291:604, 1985.
Kriss JP, Radioisotopic thyroidolymphography in patients with Graves’ disease, J Clin Endocrinol Metab 31:315–324, 1970.
Konishi J, Herman MM, Kriss JP, Binding of thyroglobulin and thyroglobulin-antithyroglobulin immune complex to extraocular muscle membrane, Endocrinology 96:434–446, 1974.
Kriss JP, Konishi J, Herman MM, Studies on the pathogenesis of Graves’ ophthalmopathy (with some related observations regarding therapy), Recent Prog Hormone Res 31:533–566, 1975.
Kriss JP, Mehdi SQ, Cell mediated lysis of lipid vesicles containing eye muscle proteins: implications regarding pathogenesis of Graves’ ophthalmopathy, Proc Natl Acad Sci USA 76:2003–2007, 1979.
Takeda Y, Kriss JP, Radiometric measurement of thyroglobulin-antithyroglobulin immune complex in human serum, J Clin Endocrinol Metab 44:46–55, 1977.
Ohtaki S, Endo Y, Horinouchi K, Yoshitake S, Ishikawa E, Circulating thyroglobulin-antithyroglobulin immune complex in thyroid diseases using enzyme-linked immunoassays, J Clin Endocrinol Metab 52:239–246, 1981.
Izumi M, Larsen PR, Correlation of sequential changes in serum, thyroglobulin, triiodothyronine, and 1-thyroxine in patients with Graves’ disease and subacute thyroiditis, Metabolism 27:582–593, 1967.
Kriss JP, Pleshakov V, Rosenblum AL, Holderness M, Sharp G, Utiger R, J Clin Endocrinol Metab 27:582–593, 1967.
Naffziger HC, Jones OW Jr, Surgical treatment of progressive exophthalmos following thyroidectomy, J Am Med Assoc 99:638–642, 1932.
Kriss JP, Pathogenesis and treatment of Graves’ ophthalmopathy, Thyroid Today 7, 1984.
Mullin BR, Levinson RE, Friedman A, Henson DE, Winand RJ, Kohn LD, Delayed hypersensitivity in Graves’ disease and exophthalmos: identification of thyroglobulin in normal human orbital muscle, Endocrinology 100:351–366, 1979.
Tao TW, Cheng P, Pham H, Leu SL, Kriss JP, Monoclonal antithyroglobulin antibodies derived from immunization of mice with human eye muscle and thyroid membranes, J Clin Endocrinol Metab 63:577–582, 1986.
Sattler H, Basedow’s Disease (translated by Marchand GW, Marchand JF), Grune and Stratton NY, pp 27-41, 1952.
Kuroki T, Ruf J, Whelan L, Miller A, Wall JR, Antithyroglobulin monoclonal and autoantibodies cross-react with an orbital connective tissue membrane antigen: a possible mechanism for the association of ophthalmopathy with autoimmune thyroid disorders, Clin Exp Immunol 62:361–370, 1985.
Winand R J, Kohn LD, The binding of H-labeled exophthalmogenic factor by plasma membranes of retro-orbital tissue, Proc Natl Acad Sci 69:1711–1715, 1972.
Winand RJ, Kohn LD, Stimulation of adenylate cyclase activity in retro-orbital tissue membranes by thyroglobulin and exophthalmogenic factor derived from thyrotropin, J Biol Chem 250:6522–6526, 1975.
Bolonkin D, Tate RL, Luber JH, Kohn LD, Experimental exophthalmos binding of thyrotropin and an exophthalmogenic factor derived from thyrotropin to retro-orbital tissue plasma membranes, J Biol Chem 250:6516–6521, 1975.
Kohn LD, Winand R J, Pathogenesis of human and experimental exophthalmos, In Proceedings of the Fourth International Congress of Endocrinology (ed. Scow RO), Excerpta Medica, Amsterdam, p 1150, 1982.
Rotella C, Zonefrati R, Toccafondi R, Valente WA, Kohn LD, Ability of monoclonal antibodies to the thyrotropin receptor to increase collagen synthesis in human fibroblasts: an assay which appears to measure exophthalmogenic immunoglobulins in Graves’ sera, J Clin Endocrinol Metab 62:357–367, 1986.
Bahn RS, Gorman CA, Woloschak GE, Johnson CM, Serum IgG from patients with Graves’ disease binds to a 23 KD protein from human retro-ocular connective tissue, 61st Meeting, Am Thy Assoc, Abst T9, 1986.
Kodama K, Sikorska H, Bayly R, Bandy-Dafoe P, Wall JR, Use of monoclonal antibodies to investigate a possible role of thyroglobulin in the pathogenesis of Graves’ ophthalmopathy, J Clin Endocrinol Metab 59:67–73, 1984.
Donaldson SS, Bagshaw MA, Kriss JP, Supervoltage orbital radiotherapy for Graves’ ophthalmopathy, J Clin Endocrinol Metab 37:276, 1973.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Plenum Press, New York
About this chapter
Cite this chapter
Kriss, J.P., McDougall, I.R., Donaldson, S.S., Kraemer, H.C. (1987). Non-Thyroidal Complications of Graves’ Disease: Perspective On Pathogenesis And Treatment. In: Pinchera, A., Ingbar, S.H., McKenzie, J.M., Fenzi, G.F. (eds) Thyroid Autoimmunity. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0945-1_31
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0945-1_31
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8258-7
Online ISBN: 978-1-4613-0945-1
eBook Packages: Springer Book Archive